The Piotroski Score is a financial metric used to evaluate a company’s overall financial health, ranging from 0 to 9. Higher scores indicate stronger fundamentals, making it a popular tool among value investors to spot solid investment opportunities. Conversely, lower scores point to weaker financial stability and potentially higher investment risk.

Financially strong stocks belong to companies with robust fundamentals such as steady revenue growth, consistent profits, healthy cash flows, and solid market presence. These Large-cap firms are often viewed as dependable options for long-term growth, appealing to conservative investors even during economic slowdowns.

Here are a few financially strong large-cap stocks that have a high Piotroski score of 9

Torrent Pharmaceuticals Limited

With a market capitalization of Rs. 122,105.63 crore, the shares of Torrent Pharmaceuticals Limited closed at Rs. 3,608 per equity share, up nearly 2.62 percent from its previous day’s close price of Rs. 3,515.90. 

Torrent Pharmaceuticals Limited has a high Piotroski score of 9, and the company’s revenue has increased from Rs. 2,745 crore in Q4 FY24 to Rs. 2,959 crore in Q4 FY25, which has grown by 7.80 percent. The net profit has also grown by 10.91 percent, from Rs. 449 crore in Q4 FY24 to Rs. 498 crore in Q4 FY25.

Torrent Pharmaceuticals Limited was established in 1959 and is engaged in research, development, manufacturing, and marketing of branded and generic pharmaceuticals across cardiovascular, CNS, gastro-intestinal, anti-diabetic, oncology, and other therapeutic areas, operating in India and over 50 countries.

Sun Pharmaceutical Industries Limited

With a market capitalization of Rs. 408,080.93 crore, the shares of Sun Pharmaceutical Industries Limited closed at Rs. 1,700.85 per equity share, rising nearly 0.52 percent from its previous day’s close price of Rs. 1,692.10. 

Sun Pharmaceutical Industries Limited has a high Piotroski score of 9, and the company’s revenue has increased from Rs. 11,983 crore in Q4 FY24 to Rs. 12,959 crore in Q4 FY25, which has grown by 8.14 percent. The net profit has decreased by 18.99 percent, from Rs. 2,659 crore in Q4 FY24 to Rs. 2,154 crore in Q4 FY25.

Sun Pharmaceutical Industries Limited was established in 1983 and is engaged in manufacturing and marketing branded and generic pharmaceuticals, APIs, and specialty products across multiple therapies, operating more than 40 manufacturing plants worldwide and serving more than 100 countries as India’s largest pharma company.

Indian Hotels Company Limited

With a market capitalization of Rs. 106,216.51 crore, the shares of Indian Hotels Company Limited closed at Rs. 746.20 per equity share, down nearly 1.03 percent from its previous day’s close price of Rs. 753.95. 

Indian Hotels Company Limited has a high Piotroski score of 9, and the company’s revenue has increased from Rs. 1,550 crore in Q1 FY25 to Rs. 2,041 crore in Q1 FY26, which has grown by 31.68 percent. The net profit has also grown by 26.54 percent, from Rs. 260 crore in Q1 FY25 to Rs. 329 crore in Q1 FY26.

Indian Hotels Company Limited was established in 1902 and is engaged in owning, operating, and managing hotels, resorts, palaces, safaris, and catering services globally, with leading brands like Taj, Vivanta, SeleQtions, and Ginger, headquartered in Mumbai

Written By Nikhil Naik

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.